Insulin Sensitivity: Clinical Trials

5 trials for Insulin Sensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown, 1 withdrawn. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Unknown 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow Insulin Sensitivity: new trials by email Literature Review of Insulin Sensitivity trials Research Report on Insulin Sensitivity

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Triticum Aestivum vs Placebo on Metabolic Profile Components and Insulin Sensitivity in Patients With Obesity
Triticum Aestivum, Placebo (calcined magnesia) - Obesity, Drug Effect
Phase 3UnknownCoordinación de Investigación en Salud, Mexico362022-07-142024-07-15
Antecedent Metabolic Health and Metformin Aging Study
Metformin, Placebo oral tablet - Aging, Insulin Sensitivity
Phase 3CompletedOklahoma Medical Research Foundation1662020-07-292026-11-05
Insulin Signaling in Skeletal Muscle
Metformin, Pioglitazone, Placebo - Insulin Sensitivity
Phase 2 / Phase 3WithdrawnWayne State University2019-09-012020-10-08
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers
Intralipid, ClinOleic, Dextrose - Diseases, Metabolic, Insulin Sensitivity
Phase 2 / Phase 3CompletedEmory University122008-06-012014-12-31
PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives
Metformin, oral contraceptive - Polycystic Ovarian Syndrome, Insulin Sensitivity
Phase 3CompletedFederico II University202006-12-012009-10-14

Narrower conditions

Insulin Resistance (5)  ·  Chronic Disease (1)  ·  Metabolic Diseases (1)  ·  Obesity (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Glucose Metabolism Disorders (5)  ·  Hyperinsulinism (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Metabolic Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Adnexal Diseases (1)  ·  Body Weight (1)  ·  Cysts (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Gonadal Disorders (1)

Interventions

Metformin (3)  ·  Biguanides (1)  ·  ClinOleic (1)  ·  Contraceptives, Oral (1)  ·  Flour (1)  ·  Glucose (1)  ·  Pioglitazone (1)  ·  Sodium Chloride (1)  ·  soybean oil, phospholipid emulsion (1)

Sponsors

Coordinación de Investigación en Salud, Mexico (1)  ·  Emory University (1)  ·  Federico II University (1)  ·  Oklahoma Medical Research Foundation (1)  ·  Wayne State University (1)

Countries

United States (2)  ·  Mexico (1)

Top investigators

Adam Konopka, PhD (1)  ·  Annamaria Colao, MD PhD (1)  ·  Benjamin F Miller, PhD (1)  ·  Guillermo Umpierrez, MD (1)

Results publications

PMID 20671408, PMID 21832112, PMID 21846339, PMID 34865016

NIH funding

R01AG064951 (1)